Harrington Discovery Institute and ASCI honor Jeffrey M. Friedman, MD, PhD
CLEVELAND, OH – March 15, 2016
The American Society for Clinical Investigation and the Harrington Discovery Institute are pleased to announce that the 2016 Harrington Prize for Innovation in Medicine has been awarded to Jeffrey M. Friedman, MD, PhD, Investigator, Howard Hughes Medical Institute and Director, Starr Center for Human Genetics, The Rockefeller University in New York City. Dr. Friedman is being recognized for pioneering insights into hormonal control of energy balance, which have provided the foundation for novel approaches to the treatment of metabolic diseases. In the mid-1990s, his laboratory identified the hormone leptin and its receptor as a new endocrine system regulating appetite and body weight. Over the ensuing years, this work has had significant therapeutic impact on the treatment of leptin-deficiency states, lipodystrophy and, increasingly, for more common metabolic conditions such as obesity and diabetes. In recognition of these contributions, Dr. Friedman has received numerous scientific awards including the Albert Lasker Award in Basic Medical Research (also known as the American Nobel).